Clinical Trials Logo

Clinical Trial Summary

With the availability of effective anti-retroviral therapy, HIV-infected individuals are expected not to die of AIDS and have longer life expectancy. But at the same time, HIV-associated non-AIDS (HANA) conditions are becoming more important in their clinical management. It is currently uncertain whether patients started on different anti-retroviral regimens will have different incidence of HANA conditions.

This study aims to evaluate the incidence of various HANA conditions in a cohort of newly diagnosed HIV-infected individuals in Hong Kong initiating anti-retroviral treatment. The incidence of various HANA conditions will be evaluated for those receiving INSTI versus other non-INSTI-based regimens.

The HANA conditions evaluated will include 1. Hypertension 2. Diabetes and insulin resistance 3. Dyslipidemia 4. Lipodystrophy 5. Metabolic syndrome 6. Osteopenia and osteoporosis 7. Vitamin D deficiency 8. Renal impairment and kidney tubular dysfunction and 9. Liver fibrosis. Patients will be assessed prior to initiation of anti-retroviral therapy, and 48 weeks and 96 weeks after initiation of treatment. The incidence of development of each HANA condition will be determined and compared between those initiated different anti-retroviral regimens.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03483584
Study type Observational
Source Chinese University of Hong Kong
Contact Rity Wong
Phone +85235053376
Email ritywong@cuhk.edu.hk
Status Not yet recruiting
Phase
Start date April 6, 2018
Completion date January 2021

See also
  Status Clinical Trial Phase
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT03477279 - Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi N/A
Recruiting NCT03483857 - Peer Navigation to Improve Engagement in Care for HIV-Positive Men Who Have Sex With Men in Ehlanzeni, South Africa N/A
Not yet recruiting NCT03487796 - MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the South N/A
Not yet recruiting NCT03340428 - Corrections2Community (iThuba II) N/A
Recruiting NCT02924389 - Dolutegravir in Reservoirs N/A
Recruiting NCT02887209 - A Pragmatic Pilot Study of Cognitive Behavioural Therapy for Insomnia Among People Living With HIV N/A
Recruiting NCT02929069 - A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk N/A
Recruiting NCT03160183 - Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
Recruiting NCT03027258 - Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome N/A
Recruiting NCT02856269 - Zinc Supplementation and Cardiovascular Risk in HIV N/A
Recruiting NCT03059121 - The Cleveland Cardiometabolic Cohort
Active, not recruiting NCT02869776 - Integrating HCV and HIV Screening During the Era of HIV Antigen Testing N/A
Completed NCT02931422 - Financial Incentives to Increase Pediatric HIV Testing Pilot Study (FIT-Pilot) N/A
Not yet recruiting NCT02906215 - Mobile Application to Improve Care Coordination Among HIV Clinic and Substance Use Treatment Providers Phase 1
Not yet recruiting NCT02844634 - Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM Phase 4
Recruiting NCT02272946 - Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk Phase 2
Recruiting NCT02384395 - Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection N/A